ELAB (PMGC Holdings Inc.) stock: $1.61, $1.3M market cap, $18.1M cash, -$16.8M EV, $14.9M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
What they do
Our lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. ● PMGC Capital LLC (“PMGC Capital”) is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets.
Partnerships MOA: exclusive license to commercialize under MOA patent rights (economics not stated in excerpts)
Indications
Muscle preservation in combination with weight-loss therapeutics (e.g. GLP-1 agonists)(Phase 1)
Status note Completed Phase 1 in South Korea in healthy volunteers. Company working toward FDA IND (subject to working capital) or a partnership to complete/submit IND.
Partnerships MOA: exclusive license to commercialize under MOA patent rights (economics not stated in excerpts)
Indications
Muscle preservation in combination with weight-loss therapeutics(Stage not disclosed)
Status note Preclinical program.
Per-asset detail extracted from the 10-Q filed 2026-08-14. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
Specialist fund holders
Tracked specialist funds: ADAR1 Capital Management, Aisling Capital, Ally Bridge Group, Avoro Capital Advisors, BVF Partners, Baker Bros. Advisors, Boxer Capital, Braidwell LP, Casdin Capital, Cormorant Asset Management, DAFNA Capital, Deerfield Management, EcoR1 Capital, Frazier Life Sciences, Great Point Partners, Ikarian Capital, Logos Global Management, OrbiMed Advisors, Perceptive Advisors, RA Capital Management, RTW Investments, Sphera Biotech, Stonepine Capital, Tang Capital Partners, Vivo Capital.
None of the tracked specialist funds reported a position in the latest 13F snapshot.
Latest news
Loading headlines…
Headlines from the Fully Diluted live wire: IR newsrooms, newswires, SEC filings, and halt notices, refreshed every 15 minutes.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 721 stocks.